Melanoma, Cutaneous Malignant, Susceptibility To, 1; Cmm1
Description
Malignant melanoma is a neoplasm of pigment-producing cells called melanocytes that occurs most often in the skin, but may also occur in the eyes, ears, gastrointestinal tract, leptomeninges, and oral and genital mucous membranes (summary by Habif, 2010).
Genes related to Melanoma, Cutaneous Malignant, Susceptibility To, 1; Cmm1
- CDKN2A
Clinical Features
Top most frequent phenotypes and symptoms related to Melanoma, Cutaneous Malignant, Susceptibility To, 1; Cmm1
- Neoplasm
- Abnormality of the eye
- Retinopathy
- Nevus
- Neoplasm of the skin
- Melanoma
- Sarcoma
- Melanocytic nevus
- Colon cancer
- Freckling
And another 11 symptoms. If you need more information about this disease we can help you.
Incidence and onset information
— Currently we don't have prevalence information about this disease (Not enough data available about incidence and published cases.)— No data available about the known clinical features onset.
Alternative names
Melanoma, Cutaneous Malignant, Susceptibility To, 1; Cmm1 Is also known as familial atypical mole-malignant melanoma syndrome, b-k mole syndrome, melanoma, familial, dns, dysplastic nevus syndrome, hereditary, cmm, melanoma, cutaneous malignant, mlm, fammm, melanoma, malignant.
Researches and researchers
Currently, we don't have any information about doctors, researches or researchers related to this disease. Please contact us if you would like to appear here.Melanoma, Cutaneous Malignant, Susceptibility To, 1; Cmm1 Recommended genes panels
Panel Name, Specifity and genes Tested/covered |
---|
Hereditary Melanoma Panel.
By Baylor Miraca Genetics Laboratories (United States).
BRCA2, TP53, CDK4, CDKN2A
Specificity
25 %
Genes
100 % |
Hereditary Pancreatic Cancer Panel.
By Baylor Miraca Genetics Laboratories (United States).
BMPR1A, BRCA1, BRCA2, STK11, EPCAM, TP53, CDK4, CDKN2A, PALB2, APC, SMAD4, MLH1, MSH2, MSH6, ATM, PMS2, RAD50
Specificity
6 %
Genes
100 % |
Comprehensive Hereditary Cancer Panel.
By Baylor Miraca Genetics Laboratories (United States).
RUNX1, SDHA, SDHB, SDHC, SDHD, BMPR1A, BRCA1, BRCA2, STK11, EPCAM, TP53, VHL, WT1, CBL, SUFU, CDC73, CDH1, CDK4, CDKN1C, CDKN2A , (...)
View the complete list with 39 more genes
Specificity
2 %
Genes
100 % |
Hereditary Colorectal/Gastrointestinal Cancer Panel.
By Baylor Miraca Genetics Laboratories (United States).
BMPR1A, BRCA1, BRCA2, STK11, EPCAM, TP53, CDH1, CDK4, CDKN2A, PALB2, ENG, APC, SMAD4, MLH1, MSH2, MSH6, MUTYH, ATM, PMS1, PMS2 , (...)
View the complete list with 1 more genes
Specificity
5 %
Genes
100 % |
Familial Malignant Melanoma.
By Center for Human Genetics, Inc (United States).
CDKN2A
Specificity
100 %
Genes
100 % |
Inherited Cancer Panel.
By Knight Diagnostic Laboratories - Molecular Diagnostic Center Oregon Health & Science University (United States).
BLM, SDHB, BMPR1A, BRCA1, BRCA2, STK11, EPCAM, TP53, TSC1, TSC2, VHL, XRCC2, CDC73, CDH1, CDK4, CDKN1B, CDKN2A, BRIP1, SDHAF2, TMEM127 , (...)
View the complete list with 28 more genes
Specificity
3 %
Genes
100 % |
MyeloidDx by NGS.
By Molecular Genetics Diagnostic Laboratory Detroit Medical Center University Laboratories (United States).
RUNX1, SF3B1, SRSF2, BRAF, SMC1A, STAG2, TP53, U2AF1, KDM6A, WT1, IKZF1, CALR, CBL, CBLB, SETBP1, FBXW7, CDKN2A, PHF6, ASXL1, CEBPA , (...)
View the complete list with 32 more genes
Specificity
2 %
Genes
100 % |
MyeloidDx by NGS.
By Molecular Genetics Diagnostic Laboratory Detroit Medical Center University Laboratories (United States).
RUNX1, SF3B1, SRSF2, BRAF, SMC1A, STAG2, TP53, U2AF1, KDM6A, WT1, IKZF1, CALR, CBL, CBLB, SETBP1, CBLC, FBXW7, CDKN2A, PHF6, CEBPA , (...)
View the complete list with 31 more genes
Specificity
2 %
Genes
100 % |
You can get up to 174 more panels with our dedicated tool
Learn moreSources and references
You can check the following sources for additional information.
OMIM Genetic Syndrome FinderIf you liked this article maybe you will also find interesting the following in-depth articles about other rare diseases, like SECKEL SYNDROME PELGER-HUET ANOMALY; PHA